NVAX Stock Price: Novavax Inc. gains as COVID-19 vaccines hit front-page news after President Trump’s recovery

NASDAQ:NVAX adds a futrther 0.93% to Wednesday's gains as broader markets bounce back.
NVAX is one biotech firm to watch after partnering with Serum Institute of India.
Novavax investors await results of Phase 3 of its clinical trials.

Stocks Reporter FXStreet

It has been a historic year for biotech firms as the emergency need for a COVID-19 vaccine has put many small firms on the radars of investors. NASDAQ:NVAX is at the top of that list and after gaining over 4600% year to date, the stock still could have room to move if the results of its Phase 3 clinical trials are successful. On Thursday, Novavax rose 0.93% to close the day at $111.02, which means the stock is still trading at a 40% discount from its 52-week high of $189.40. The stock is trading right at its 50-day moving average which shows how flat shares have been even through some encouraging announcements from the firm.

In late September, the Maryland-based biotech company announced a partnership with the largest manufacturer of vaccines in the world at the Serum Institute of India. The deal led to estimates of over 2 billion annual doses of its vaccine candidate: NVX‑CoV2373 for low-income countries which includes India. Considering these reports from the company, the stock has not moved up over the past couple of months which may be an indication that investors are exercising caution over which biotech company will emerge as the successful candidate.

NVAX stock news

As the global economy continues its volatility heading into the final quarter of 2020, investors who are looking to Novavax as a possible horse to back in the race for a vaccine may want to take the plunge now before it is too late. Expect the stock to get a boost if a successful Phase 3 result is reported, and with a mean analyst price target of $227.60, these may be the lowest levels the stock sees for quite some time.

Author

Stocks Reporter

FXStreet

GBP/USD hits fresh three-month highs above 1.3550

GBP/USD stretches north and refreshes three-month highs above 1.3500 in the European session on Monday. The prevalent US Dollar selling bias favors bullish traders and suggests that the path of least resistance for the pair remains to the upside.

EUR/USD extends gains above 1.1600 on USD weakness

EUR/USD extends its advance above 1.1600 in European trading hours on Monday. The US Dollar resumes its downside amid weaker-than-expected US economic data, shifting Fed expectations and fading geopolitical risk premium.

Gold looks to build strength above $4,400 amid fading Fed hike bets

Gold builds on Friday's bounce from the $4,300 neighborhood and attracts some follow-through buyers at the start of a new week. The commodity is now looking to extend momentum above the $4,400 mark, though it remains below the highest level since June 5, touched last Thursday, amid mixed fundamental cues.

Pepe defends a key support amid mixed retail demand

Pepe is up nearly 2% after a 10% decline last week, showing signs of a mild recovery, while broader crypto market risk appetite remains weak. PEPE derivatives data point to a mixed outlook, as Open Interest declines while funding rates turn positive. Technically, PEPE must hold above its $0.00000255 support floor to avoid a downside of over 10%.

Why the Fed replaced the Treasury buyers who left

When Japan moved to defend the Yen, the arrangement that drew the attention was the Federal Reserve's repo facility for foreign monetary authorities, which lets an approved foreign central bank raise dollars by temporarily handing Treasuries to the Fed rather than selling them into the market. The logic was elegant. Japan gets dollars, the Treasury market avoids a forced seller, and American long rates are spared. Coverage treated it as the mechanism that made the intervention work.

Why is Crude Oil priced for a reopening the ships haven't made?

Fourteen vessels crossed the Strait of Hormuz on Tuesday. Before the war, the count ran near 120 a day. In the sessions since the waterway was publicly declared open, Brent has drifted back to $87 and West Texas Intermediate (WTI) to $81, both a little lower again on Wednesday, with daily momentum on each unwound from the top of its range in late July to the low twenties now.